PTJ
OLMA icon

Paul Tudor Jones’s Olema Pharmaceuticals OLMA Stock Holding History

Paul Tudor Jones’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-12,745
Closed -$44K – 2791
2023
Q1 		$44K Sell
12,745
-7,131
-36% -$29.1K ﹤0.01% 2290
2022
Q4 		$49K Hold
19,876
– – ﹤0.01% 2247
2022
Q3 		$55K Buy
+19,876
New +$84.3K ﹤0.01% 2185

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $143M AUM 102.52% 1-Year Est. Return

Paul Tudor Jones's OLMA Position: Q2 2023 in Review

Paul Tudor Jones sold out of Olema Pharmaceuticals (OLMA) in Q2 2023, closing a stake of 12,745 shares — an estimated $44K sold.

Paul Tudor Jones first reported a position in OLMA in Q3 2022 and held it in 3 quarters. The position peaked at $55K in Q3 2022. 87 funds tracked by Wall St. Rank hold OLMA as of Q2 2023.

  • Paul Tudor Jones reported no remaining Olema Pharmaceuticals position as of Q2 2023 after selling out during the quarter.
  • Paul Tudor Jones sold 12,745 Olema Pharmaceuticals shares in Q2 2023, an estimated $44K.
  • Paul Tudor Jones first reported a position in Olema Pharmaceuticals in Q3 2022 and held it in 3 quarters.
  • Paul Tudor Jones's Olema Pharmaceuticals position peaked at $55K in Q3 2022.
  • 87 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.